Literature DB >> 4276368

A short-term double-blind controlled trial of prenazone (DA 2370) in rheumatoid arthritis.

P J Rooney, C Watkins, S J Ahola, G I Gray, W C Dick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4276368     DOI： 10.1185/03007997409111740

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  3 in total

1.  Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.

Authors:  M R Fletcher; W Loebl; J T Scott
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

2.  An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species.

Authors:  K D Rainsford
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

Review 3.  Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity.

Authors:  Helga Radner; Sofia Ramiro; Rachelle Buchbinder; Robert B M Landewé; Désirée van der Heijde; Daniel Aletaha
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.